BCR and neoplasm: Evaluation of CDR3 sequence identity in paired samples revealed reduction in BCR repertoire diversity (inversely related to clonality score) in subsequent tumor samples, indicative of clonal enrichment at time of relapse and is supportive of an evolutionary dynamic driven by clonal selection and expansion (Fig. 5F).